search icon
Vaxcyte shares decline ahead of VAX-24 topline results webcast
Catalyst Color

Vaxcyte shares decline ahead of VAX-24 topline results webcast

In this article

PCVX+4.2%

Vaxcyte, Inc. shares are trading lower after announcing an upcoming webcast and conference call to present topline results from its VAX-24 Infant Phase 2 Study, causing investor uncertainty.

More Articles

Edible Garden shares fall on wider 2024 loss despite higher gross profit

Edible Garden shares fall on wider 2024 loss despite higher gross profit

Mar 31, 2025
BioCardia shares gain on 2024 highlights, CardiAMP HF trial momentum

BioCardia shares gain on 2024 highlights, CardiAMP HF trial momentum

Mar 31, 2025
Newton Golf shares climb on record 2024 results, product launches, global growth

Newton Golf shares climb on record 2024 results, product launches, global growth

Mar 31, 2025